Regarding the duality of TAMs in different tumors, an interesting study conducted with patients diagnosed with triple-negative breast cancer (TNBC) found that TAMs displayed high levels of CD163+ and, therefore, an M2-like phenotype. Here, CD163 is linked to triple-negative breast carcinoma.